NCT02609789: A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus |
|
|
| Completed | 1 | 72 | US, Europe, RoW | JNJ-55920839, CNTO 6358, Placebo | Janssen Research & Development, LLC | Systemic Lupus Erythematosus, Healthy | 09/18 | 09/18 | | |
